The author presents data on the incidence of diseases involving temporary invalidity among workers of the Moscow Railway. The difference in morbidity levels at various enterprises in this branch of industry is as high as 2.9 to 5.9 times, which fact is regarded as a sign of uncontrollable increase of morbidity among the workers of the predominant part of the production. A system of registration and organizational measures aimed at morbidity prevention, conditionally named Automated Monitoring System 'Morbidity' (AMSM) is presented. Results of distribution of morbidity by "days" in the final line 30 of record file 16BH in relative compatible parameters are described. Introduction of AMSM resulted in reduction of morbidity in 1993 as reflected in line 35 in "days" by 10% vs. the year 1992 and in a different rating of a test enterprise TC-18 in the total group of the Moscow Railway Depot, which moved from the 4th to 10th position. Economical estimation of the benefit due to morbidity reduction and validation of cost efficacy and self support of AMSM are presented.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Analysis of the mechanical properties of a material of temporary structures manufactured by direct method and provisional crowns made by 3D printing].
Stomatologiia (Mosk)
December 2024
LLC "KHARTS Labs", Moscow, Russia.
Unlabelled: The aim of this work is to study the mechanical properties of temporary composite crowns and temporary composite orthopedic structures manufactured by 3D printing.
Materials And Methods: For the two studied groups of samples: the original 3D-printed samples and the poured samples from a composite material of a certain shape, 8 samples were made and visually checked for the absence of porosity. The strength and elasticity were measured using the three-point bending method and the hardness was measured using the indentation method.
Mannitol for bowel preparation: Efficacy and safety results from the SATISFACTION randomised clinical trial.
Dig Liver Dis
February 2025
Praxis für Gastroenterologie und Fachärztliche Innere Medizin, Im Haus der Gesundheit, Ludwigshafen am Rhein, Germany.
Background: Bowel preparation represents a significant issue to high-quality colonoscopy. Oral mannitol requires a single dose, is of low volume, and has a pleasant taste and rapid action.
Aims: This SATISFACTION study compared single-dose (same day) oral mannitol 100 g/750 mL with standard split-dose PEG-ASC2 L (MoviPrep®).
Recombinant collagen coating 3D printed PEGDA hydrogel tube loading with differentiable BMSCs to repair bile duct injury: The deficiency of engineering approaches in tissue engineering research.
Colloids Surf B Biointerfaces
January 2025
National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia; Obninsk Institute for Nuclear Power Engineering, National Research Nuclear University MEPhI, Obninsk, Russia. Electronic address:
Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study.
Dokl Biochem Biophys
October 2024
Mechnikov North-Western State Medical University, 191015, St. Petersburg, Russia.
Article Synopsis
- Netakimab has shown effective results in controlled trials for treating ankylosing spondylitis (AS), and this study investigates its efficacy and safety in everyday clinical settings over a year.
- The observational study included 137 patients from 23 centers in Russia, focusing on retention rates and the impact of netakimab therapy at multiple time points during the year.
- Findings revealed that 90.4% of patients continued treatment after one year, and significant improvements were observed in disease activity scores, with only a small percentage experiencing adverse effects.
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR.
Dokl Biochem Biophys
October 2024
JSC BIOCAD, St. Petersburg, Russia.
Unlabelled: . Previously, 24-week results of phase III double-blind, placebo-controlled randomized clinical study (SOLAR) of levilimab in subjects with active rheumatoid arthritis (RA) proved a superiority of levilimab over placebo. Here, we present 1-year efficacy and safety data of the SOLAR study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!